Amniotic Fluid Natriuretic Peptide Levels in Fetuses With Congenital Heart Defects or Arrhythmias
-
- Miyoshi Takekazu
- Department of Perinatology and Gynecology, National Cerebral and Cardiovascular Center Department of Obstetrics and Gynecology, Mie University
-
- Hosoda Hiroshi
- Department of Regenerative Medicine and Tissue Engineering, National Cerebral and Cardiovascular Center
-
- Umekawa Takashi
- Department of Obstetrics and Gynecology, Mie University
-
- Asada Takashi
- Laboratory of Clinical Chemistry, National Cerebral and Cardiovascular Center
-
- Fujiwara Akihiro
- Laboratory of Clinical Chemistry, National Cerebral and Cardiovascular Center
-
- Kurosaki Ken-ichi
- Department of Pediatric Cardiology, National Cerebral and Cardiovascular Center
-
- Shiraishi Isao
- Department of Pediatric Cardiology, National Cerebral and Cardiovascular Center
-
- Nakai Michikazu
- Department of Statistics and Data Analysis, Center for Cerebral and Cardiovascular Disease Information, National Cerebral and Cardiovascular Center
-
- Nishimura Kunihiro
- Department of Statistics and Data Analysis, Center for Cerebral and Cardiovascular Disease Information, National Cerebral and Cardiovascular Center
-
- Miyazato Mikiya
- Department of Biochemistry, National Cerebral and Cardiovascular Center
-
- Kangawa Kenji
- Department of Biochemistry, National Cerebral and Cardiovascular Center
-
- Ikeda Tomoaki
- Department of Obstetrics and Gynecology, Mie University
-
- Yoshimatsu Jun
- Department of Perinatology and Gynecology, National Cerebral and Cardiovascular Center
-
- Minamino Naoto
- Omics Research Center, National Cerebral and Cardiovascular Center
この論文をさがす
抄録
<p>Background: We have previously demonstrated that umbilical cord plasma natriuretic peptide (NP) levels reflect the severity of heart failure (HF) in fetuses with congenital heart defects (CHD). The aim of this study was to evaluate the significance of amniotic fluid (AF) NP levels in the assessment of HF in fetuses with CHD or arrhythmia. </p><p>Methods and Results: This was a prospective observational study at a tertiary pediatric cardiac center. A total of 95 singletons with CHD or arrhythmia, and 96 controls from 2012 to 2015 were analyzed. AF concentrations of atrial NP (ANP), B-type NP (BNP) and N-terminal pro-B-type NP (NT-proBNP) at birth were compared with ultrasonographic assessment of fetal HF using the cardiovascular profile (CVP) score. Multivariate analysis showed that a CVP score ≤5 and preterm birth are independently associated with high AF NT-proBNP levels. AF NT-proBNP levels of fetuses with CHD or arrhythmia inversely correlated with CVP score (P for trend <0.01). In contrast, AF concentrations of ANP and BNP were extremely low, and it was difficult to assess the degree of fetal HF based on them. </p><p>Conclusions: AF NT-proBNP concentrations increase in stepwise fashion with the severity of HF in fetuses with CHD or arrhythmia; it was the optimal NP for assessing the fetal HF. </p>
収録刊行物
-
- Circulation Journal
-
Circulation Journal 82 (10), 2619-2626, 2018-09-25
一般社団法人 日本循環器学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001288072492032
-
- NII論文ID
- 130007487116
-
- NII書誌ID
- AA11591968
-
- ISSN
- 13474820
- 13469843
-
- NDL書誌ID
- 029230168
-
- PubMed
- 29998930
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可